{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T09:35:50Z","timestamp":1786440950067,"version":"build-2736575974"},"reference-count":27,"publisher":"Charles University in Prague, Karolinum Press","issue":"2","license":[{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":222,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"tdm","delay-in-days":222,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["actamedica.lfhk.cuni.cz"],"crossmark-restriction":true},"short-container-title":["Acta Med. (Hradec Kralove, Czech Repub.)"],"published-print":{"date-parts":[[2026]]},"abstract":"<jats:p>Cytotoxic chemotherapy remains integral to contemporary uro-oncology despite the rapid expansion of targeted therapy, antibody-drug conjugates, and immunotherapy. Its role is especially critical where therapeutic success depends on maintaining adequate dose intensity, most notably in metastatic testicular germ cell tumours and in cisplatin-based perioperative treatment for muscle-invasive bladder cancer. In metastatic prostate cancer and selected penile squamous cell carcinoma, taxane- and platinum-based regimens also retain clinical value but are constrained by hematologic, neurologic, renal, pulmonary, and gastrointestinal toxicities. This narrative review summarises current evidence and guideline recommendations for Common Terminology Criteria for Adverse Events (CTCAE)-guided management of chemotherapy toxicity across major uro-oncologic disease settings. A practical emphasis is placed on pretreatment risk stratification, cycle-by-cycle surveillance, supportive care, and intent-adapted treatment modification. Across tumour types, early recognition of grade 2 toxicity, urgent management of febrile neutropenia and organ toxicity, and thoughtful preservation of dose intensity when cure is realistic are the central management principles. In older, frail, immunosuppressed, heavily pretreated, or organ-limited patients, CTCAE grades must be interpreted against baseline reserve and cumulative toxicity.<\/jats:p>","DOI":"10.14712\/18059694.2026.20","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T09:03:21Z","timestamp":1786439001000},"page":"65-71","update-policy":"https:\/\/doi.org\/10.14712\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["CTCAE-Guided Management of Cytotoxic Chemotherapy Toxicity in Uro-Oncology: A Contemporary Narrative Review"],"prefix":"10.14712","volume":"69","author":[{"given":"Minh Nguyet","family":"Tranov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleg","family":"Izmaylov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanka","family":"Princlov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Navr\u00e1til","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5727","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"key":"18059694.2026.20_1","unstructured":"European Association of Urology. EAU Guidelines on Testicular Cancer. Edn. presented at the EAU Annual Congress London, 2026. Arnhem: EAU Guidelines Office; 2026. Available at: https:\/\/uroweb.org \/guidelines\/testicular-cancer (accessed March 22, 2026)."},{"key":"18059694.2026.20_2","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1200\/JCO.20.03296","volume":"39","author":"Gillessen","year":"2021","journal-title":"J Clin Oncol."},{"key":"18059694.2026.20_3","doi-asserted-by":"crossref","first-page":"4592","DOI":"10.1073\/pnas.072067999","volume":"99","author":"Einhorn","year":"2002","journal-title":"Proc Natl Acad Sci USA."},{"key":"18059694.2026.20_4","unstructured":"European Association of Urology. EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer. Edn. presented at the EAU Annual Congress London, 2026. Arnhem: EAU Guidelines Office; 2026. Available at: https:\/\/uroweb.org\/guidelines\/muscle-invasive-and-metastatic-bladder-cancer (accessed March 22, 2026)."},{"key":"18059694.2026.20_5","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1200\/JCO.21.02051","volume":"40","author":"Pfister","year":"2022","journal-title":"J Clin Oncol."},{"key":"18059694.2026.20_6","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S1470-2045(10)70275-8","volume":"12","author":"Galsky","year":"2011","journal-title":"Lancet Oncol."},{"key":"18059694.2026.20_7","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1200\/JCO.2000.18.17.3068","volume":"18","author":"von der Maase","year":"2000","journal-title":"J Clin Oncol."},{"key":"18059694.2026.20_8","unstructured":"European Association of Urology. EAU Guidelines on Prostate Cancer. Edn. presented at the EAU Annual Congress London, 2026. Arnhem: EAU Guidelines Office; 2026. Available at: https:\/\/uroweb.org \/guidelines\/prostate-cancer (accessed March 22, 2026)."},{"key":"18059694.2026.20_9","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1056\/NEJMoa040720","volume":"351","author":"Tannock","year":"2004","journal-title":"N Engl J Med."},{"key":"18059694.2026.20_10","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0140-6736(10)61389-X","volume":"376","author":"de Bono","year":"2010","journal-title":"Lancet."},{"key":"18059694.2026.20_11","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1056\/NEJMoa1911206","volume":"381","author":"de Wit","year":"2019","journal-title":"N Engl J Med."},{"key":"18059694.2026.20_12","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s10147-024-02501-7","volume":"29","author":"Kimura","year":"2024","journal-title":"Int J Clin Oncol."},{"key":"18059694.2026.20_13","unstructured":"European Association of Urology and American Society of Clinical Oncology. EAU-ASCO Guidelines on Penile Cancer. Edn. presented at the EAU Annual Congress London, 2026. Arnhem: EAU Guidelines Office; 2026. Available at: https:\/\/uroweb.org\/guidelines\/penile-cancer (accessed March 22, 2026)."},{"key":"18059694.2026.20_14","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1200\/JCO.2010.29.5477","volume":"28","author":"Pagliaro","year":"2010","journal-title":"J Clin Oncol."},{"key":"18059694.2026.20_15","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S1053-4296(03)00031-6","volume":"13","author":"Trotti","year":"2003","journal-title":"Semin Radiat Oncol."},{"key":"18059694.2026.20_16","unstructured":"National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE), version 6.0 (MedDRA 28.0). Bethesda (MD): U.S. Department of Health and Human Services; 2025."},{"key":"18059694.2026.20_17","unstructured":"National Cancer Institute. NCI releases updated version of the Common Terminology Criteria for Adverse Events (CTCAE) reporting in clinical trials. Bethesda (MD): National Cancer Institute; 2026. Available at: https:\/\/dctd.cancer.gov\/about\/news-events\/news\/2026-news\/ctcae-updated-version-6 (accessed June 10, 2026)."},{"key":"18059694.2026.20_18","doi-asserted-by":"crossref","first-page":"102195","DOI":"10.1016\/j.esmoop.2023.102195","volume":"9","author":"Herrstedt","year":"2024","journal-title":"ESMO Open."},{"key":"18059694.2026.20_19","doi-asserted-by":"crossref","first-page":"101214","DOI":"10.1016\/j.lanepe.2025.101214","volume":"51","author":"Sandherr","year":"2025","journal-title":"Lancet Reg Health Eur."},{"key":"18059694.2026.20_20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10157-023-02386-2","volume":"28","author":"Li","year":"2024","journal-title":"Clin Exp Nephrol."},{"key":"18059694.2026.20_21","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.clgc.2016.08.021","volume":"15","author":"Necchi","year":"2017","journal-title":"Clin Genitourin Cancer."},{"key":"18059694.2026.20_22","first-page":"554","volume":"32","author":"Johnson","year":"2024","journal-title":"Support Care Cancer."},{"key":"18059694.2026.20_23","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s10549-021-06477-0","volume":"192","author":"Coolbrandt","year":"2022","journal-title":"Breast Cancer Res Treat."},{"key":"18059694.2026.20_24","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1200\/JCO.23.00933","volume":"41","author":"Dale","year":"2023","journal-title":"J Clin Oncol."},{"key":"18059694.2026.20_25","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1016\/S1470-2045(19)30145-7","volume":"20","author":"Krens","year":"2019","journal-title":"Lancet Oncol."},{"key":"18059694.2026.20_26","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41571-023-00776-9","volume":"20","author":"Lustberg","year":"2023","journal-title":"Nat Rev Clin Oncol."},{"key":"18059694.2026.20_27","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1111\/tri.14115","volume":"34","author":"Maggiore","year":"2021","journal-title":"Transpl Int."}],"container-title":["Acta Medica (Hradec Kralove, Czech Republic)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/actamedica.lfhk.cuni.cz\/media\/pdf\/am_2026069020065.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T09:03:41Z","timestamp":1786439021000},"score":1,"resource":{"primary":{"URL":"https:\/\/actamedica.lfhk.cuni.cz\/69\/2\/0065\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":27,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026]]}},"alternative-id":["am_2026069020065"],"URL":"https:\/\/doi.org\/10.14712\/18059694.2026.20","relation":{},"ISSN":["1211-4286","1805-9694"],"issn-type":[{"value":"1211-4286","type":"print"},{"value":"1805-9694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]}}}